hli logo
Image from Coce

Evidence-based dermatology / edited by Hywel Williams ; associate editors, Michael Bigby ... [et al.].

Contributor(s): Material type: TextTextPublication details: Malden, Mass. ; Oxford : Blackwell Pub./BMJ Books, 2008.Edition: 2nd edDescription: xv, 723 p. : col. ill. ; 29 cmISBN:
  • 9781405145183
  • 1405145188
  • 9781444300161
  • 1444300164
Subject(s): LOC classification:
  • RL71 .E95 2008
Contents:
Part I: The concept of evidence-based dermatology.Andrew Herxheimer, Editor.1. The field and its boundaries.2. The rationale for evidence-based dermatology.3. The role of the consumer and the public in evidence-based dermatology.4. The Cochrane Skin Group. Part II: The critical appraisal toolbox.Michael Bigby, Editor.5. Formulating well-built clinical questions.6. Finding the best evidence.7. The hierarchy of evidence.8. Appraising systematic reviews and meta-analyses.9. How to critically appraise a randomized controlled trial.10. How to assess the evidence concerning the safety of medical interventions.11. What makes a good case series?.12. What makes a good prevalence survey?.13. Critical appraisal of pharmacoeconomic studies.14. Applying the evidence back to the patient. Part III: The evidence. Part IIIa: Common inflammatory skin diseases.Luigi Naldi, Editor.15. Acne vulgaris.16. Papulopustular rosacea.17. Perioral dermatitis.18. Hand eczema.19. Atopic eczema.20. Seborrheic dermatitis.21. Psoriasis.22. Lichen planus.23. Acute urticaria.24. Chronic urticaria. Part IIIb: Skin cancer, moles, and photoaging.Hywel Williams, Editor.25. Primary prevention of skin cancer.26. Do sunscreens reduce the incidence of skin cancers?.27. Cutaneous melanoma.28. Squamous cell carcinoma.29. Basal cell carcinoma.30. Primary cutaneous T-cell lymphoma.31. Actinic keratoses and Bowen's disease.32. Kaposi's sarcoma.33. Photoaging.34. Melanocytic nevi. Part IIIc: Infective skin diseases and.exanthema.Hywel Williams and Thomas Diepgen, Editors.35. Local treatment for cutaneous warts.36. Impetigo.37. Athlete's foot.38. Onychomycosis.39. Tinea capitis.40. Deep fungal infections.41. Streptococcal cellulitis/erysipelas of the lower leg.42. Exanthematic reactions.43. Herpes simplex.44. Leprosy.45. Cutaneous leishmaniasis. Part IIId: Infestations.Berthold Rzany, Editor.46. Scabies.47. Head lice.48. Insect bites and stings. Part IIIe: Disorders of pigmentation.Berthold Rzany, Editor.49. Vitiligo.50. Melasma. Part IIIf: Hair problems.Berthold Rzany, Editor.51. Male and female androgenetic alopecia.52. Alopecia areata.53. Evidence-based treatment of hirsutism. Part IIIg: Leg ulceration.Berthold Rzany, Editor.54. Venous ulcers. Part IIIh: Other important skin disorders.55. Cutaneous lupus erythematosus.56. Dermatomyositis.57. Acquired subepidermal bullous diseases.58. Pemphigus.59. Cutaneous sarcoidosis.60. Erythema multiforme.61. Stevens-Johnson syndrome and toxic epidermal necrolysis.62. Focal hyperhidrosis.63. Polymorphic light eruption (PLE).64. Infantile hemangiomas and port-wine stains.65. Psychocutaneous disease.66. Pruritus.67. Other skin diseases for which trials exist. Part IV: The future of evidence-based.dermatology.Luigi Naldi, Editor.68. Where do we go from here?.Hywel Williams.
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Shelving location Call number Copy number Status Date due Barcode Item holds
2 Week Loan Cork University Hospital Healthcare Library Cork University Hospital Healthcare Library Open Shelves W 616.5 WILL (Browse shelf(Opens below)) 1 Available 0010289600
Total holds: 0

Includes bibliographical references and index.

Part I: The concept of evidence-based dermatology.Andrew Herxheimer, Editor.1. The field and its boundaries.2. The rationale for evidence-based dermatology.3. The role of the consumer and the public in evidence-based dermatology.4. The Cochrane Skin Group. Part II: The critical appraisal toolbox.Michael Bigby, Editor.5. Formulating well-built clinical questions.6. Finding the best evidence.7. The hierarchy of evidence.8. Appraising systematic reviews and meta-analyses.9. How to critically appraise a randomized controlled trial.10. How to assess the evidence concerning the safety of medical interventions.11. What makes a good case series?.12. What makes a good prevalence survey?.13. Critical appraisal of pharmacoeconomic studies.14. Applying the evidence back to the patient. Part III: The evidence. Part IIIa: Common inflammatory skin diseases.Luigi Naldi, Editor.15. Acne vulgaris.16. Papulopustular rosacea.17. Perioral dermatitis.18. Hand eczema.19. Atopic eczema.20. Seborrheic dermatitis.21. Psoriasis.22. Lichen planus.23. Acute urticaria.24. Chronic urticaria. Part IIIb: Skin cancer, moles, and photoaging.Hywel Williams, Editor.25. Primary prevention of skin cancer.26. Do sunscreens reduce the incidence of skin cancers?.27. Cutaneous melanoma.28. Squamous cell carcinoma.29. Basal cell carcinoma.30. Primary cutaneous T-cell lymphoma.31. Actinic keratoses and Bowen's disease.32. Kaposi's sarcoma.33. Photoaging.34. Melanocytic nevi. Part IIIc: Infective skin diseases and.exanthema.Hywel Williams and Thomas Diepgen, Editors.35. Local treatment for cutaneous warts.36. Impetigo.37. Athlete's foot.38. Onychomycosis.39. Tinea capitis.40. Deep fungal infections.41. Streptococcal cellulitis/erysipelas of the lower leg.42. Exanthematic reactions.43. Herpes simplex.44. Leprosy.45. Cutaneous leishmaniasis. Part IIId: Infestations.Berthold Rzany, Editor.46. Scabies.47. Head lice.48. Insect bites and stings. Part IIIe: Disorders of pigmentation.Berthold Rzany, Editor.49. Vitiligo.50. Melasma. Part IIIf: Hair problems.Berthold Rzany, Editor.51. Male and female androgenetic alopecia.52. Alopecia areata.53. Evidence-based treatment of hirsutism. Part IIIg: Leg ulceration.Berthold Rzany, Editor.54. Venous ulcers. Part IIIh: Other important skin disorders.55. Cutaneous lupus erythematosus.56. Dermatomyositis.57. Acquired subepidermal bullous diseases.58. Pemphigus.59. Cutaneous sarcoidosis.60. Erythema multiforme.61. Stevens-Johnson syndrome and toxic epidermal necrolysis.62. Focal hyperhidrosis.63. Polymorphic light eruption (PLE).64. Infantile hemangiomas and port-wine stains.65. Psychocutaneous disease.66. Pruritus.67. Other skin diseases for which trials exist. Part IV: The future of evidence-based.dermatology.Luigi Naldi, Editor.68. Where do we go from here?.Hywel Williams.

There are no comments on this title.

to post a comment.